Treatment and Dosimetric Advantages Between VMAT, IMRT, and Helical TomoTherapy in Prostate Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment and Dosimetric Advantages Between VMAT, IMRT, and Helical TomoTherapy in Prostate Cancer

Published:2011-09 Issue:3 Volume:36 Page:264-271
ISSN:0958-3947
Container-title:Medical Dosimetry
language:en
Short-container-title:Medical Dosimetry

Author:

Tsai Chiao-Ling,Wu Jian-Kuen,Chao Hsiao-Ling,Tsai Yi-Chun,Cheng Jason Chia-Hsien

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Radiological and Ultrasound Technology

Reference29 articles.

1. Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial;Dearnaley;Lancet. Oncol.,2007

2. Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy;Peeters;J. Clin. Oncol.,2006

3. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial;Zietman;JAMA,2005

4. Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial;Pollack;Int. J. Radiat. Oncol. Biol. Phys.,2002

5. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer;Zelefsky;Radiother. Oncol.,2000

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of volumetric modulated arc therapy and helical tomotherapy for prostate cancer using Pareto fronts;Medical Physics;2023-12-06

2. Optimal Bladder Volume for Hypofractionated Proton Therapy in Each Localized Prostate Cancer Risk Group;Cureus;2023-11-13

3. The top 100 most cited articles in helical tomotherapy: a scoping review;Frontiers in Oncology;2023-10-17

4. Dosimetric comparison between intensity-modulated radiation therapy and volumetric-modulated arc therapy to enhance bladder and bowel;Journal of Medicine and Life;2023-09

5. Advances in radiotherapy and its impact on second primary cancer risk: A multi-center cohort study in prostate cancer patients;Radiotherapy and Oncology;2023-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3